Authors:
van der Linden, YM
van Kempen, ML
van der Tweel, I
Vanderschueren, RGJRA
Schlosser, JJ
Lammers, JWJ
Struikmans, H
Citation: Ym. Van Der Linden et al., Prophylactic cranial irradiation in limited disease small-cell lung cancerin complete remission: a retrospective analysis, RESP MED, 95(3), 2001, pp. 235-236
Authors:
Poortmans, PMP
Venselaar, JLM
Struikmans, H
Hurkmans, CW
Davis, JB
Huyskens, D
van Tienhoven, G
Vlaun, V
Lagendijk, JJW
Mijnheer, BJ
De Winter, KA
Van der Hulst, MH
Van den Bogaert, WFC
Citation: Pmp. Poortmans et al., The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: A quality-assurance report on the dummy run of EORTC phase III randomized trial 22922/10925 in stage I-IIIbreast cancer, INT J RAD O, 49(5), 2001, pp. 1399-1408
Authors:
Dijkema, IM
Struikmans, H
Dullens, HFJ
Kal, HB
van der Tweel, I
Battermann, JJ
Citation: Im. Dijkema et al., Influence of p53 and bcl-2 on proliferative activity and treatment outcomein head and neck cancer patients, ORAL ONCOL, 36(1), 2000, pp. 54-60
Authors:
van Kempen-Harteveld, ML
Struikmans, H
Kal, HB
van der Tweel, I
Mourits, MP
Verdonck, LF
Schipper, J
Battermann, JJ
Citation: Ml. Van Kempen-harteveld et al., Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: Influence of treatment parameters, INT J RAD O, 48(3), 2000, pp. 807-815
Authors:
Vrieling, C
Collette, L
Fourquet, A
Hoogenraad, WJ
Horiot, JC
Jager, JJ
Pierart, M
Poortmans, PM
Struikmans, H
Maat, B
Van Limbergen, E
Bartelink, H
Citation: C. Vrieling et al., The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial, RADIOTH ONC, 55(3), 2000, pp. 219-232
Authors:
Struikmans, H
Rutgers, DH
Hordijk, GJ
van der Tweel, I
Battermann, JJ
Citation: H. Struikmans et al., Regional heterogeneity and intra-observer variability of DNA-content and cell proliferation markers determined by flow cytometry in head and neck tumours, ORAL ONCOL, 35(2), 1999, pp. 217-223
Authors:
Struikmans, H
Rutgers, DH
Jansen, GH
Dullens, HFJ
Oosten, L
Tulleken, CAF
van der Tweel, I
Battermann, JJ
Citation: H. Struikmans et al., Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2 '-deoxyuridine labeling indices, and mitotic figures in gliomas, RADIAT ON I, 7(4), 1999, pp. 243-248
Authors:
Vrieling, C
Collette, L
Bartelink, E
Borger, JH
Brenninkmeyer, SJ
Horiot, JC
Pierart, M
Poortmans, PM
Struikmans, H
Van der Schueren, E
Van Dongen, JA
Van Limbergen, E
Bartelink, H
Citation: C. Vrieling et al., Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial, INT J RAD O, 45(3), 1999, pp. 667-676
Authors:
Vrieling, C
Collette, L
Fourquet, A
Hoogenraad, WJ
Horiot, JC
Jager, JJ
Pierart, M
Poortmans, PM
Struikmans, H
Van der Hulst, M
Van der Schueren, E
Bartelink, H
Citation: C. Vrieling et al., The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial, INT J RAD O, 45(3), 1999, pp. 677-685
Authors:
Begg, AC
Haustermans, K
Hart, AAM
Dische, S
Saunders, M
Zackrisson, B
Gustaffson, H
Coucke, P
Paschoud, N
Hoyer, M
Overgaard, J
Antognoni, P
Richetti, A
Bourhis, J
Bartelink, H
Horiot, JC
Corvo, R
Giaretti, W
Awwad, H
Shouman, T
Jouffroy, T
Maciorowski, Z
Dobrowsky, W
Struikmans, H
Rutgers, D
Wilson, GD
Citation: Ac. Begg et al., The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis, RADIOTH ONC, 50(1), 1999, pp. 13-23
Citation: J. De Bree et al., Treatment planning of brain implants using vascular information and a new template technique, IEEE MED IM, 17(5), 1998, pp. 729-736